{"version":"1.0","provider_name":"Leitat Technological Center","provider_url":"https:\/\/leitat.org\/en\/","author_name":"Dissemination Manager","author_url":"https:\/\/leitat.org\/en\/blog\/author\/editor-wp\/","title":"La spin-off de Leitat, Amira therapeutics, recibe la Designaci\u00f3n de Medicamento Hu\u00e9rfano para AMI463 en Sarcoma de Tejidos Blandos en Estados Unidos - Leitat Technological Center","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"f7n95LeeRS\"><a href=\"https:\/\/leitat.org\/en\/blog\/amira-therapeutics\/\">La spin-off de Leitat, Amira therapeutics, recibe la Designaci\u00f3n de Medicamento Hu\u00e9rfano para AMI463 en Sarcoma de Tejidos Blandos en Estados Unidos<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/leitat.org\/en\/blog\/amira-therapeutics\/embed\/#?secret=f7n95LeeRS\" width=\"600\" height=\"338\" title=\"&#8220;La spin-off de Leitat, Amira therapeutics, recibe la Designaci\u00f3n de Medicamento Hu\u00e9rfano para AMI463 en Sarcoma de Tejidos Blandos en Estados Unidos&#8221; &#8212; Leitat Technological Center\" data-secret=\"f7n95LeeRS\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/leitat.org\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/04\/AMIRA.jpg","thumbnail_width":567,"thumbnail_height":313,"description":"El Grupo Operativo \u2018AlgaVid\u2019 pretende sustituir fertilizantes y abonos de origen qu\u00edmico en el vi\u00f1edo por bioproductos basados en las microalgas. Paralelamente, se desplegar\u00e1 una red de sensores dotados con Inteligencia Artificial con impacto en la producci\u00f3n, el suelo y el agua."}